Top

Published in:

01-10-2020 | Kidney Transplantation | Original Article

TNF, IL-6, and IL-10 cytokines levels and their polymorphisms in renal function and time after transplantation

Authors: Lorraine Vieira Alves, Suellen Rodrigues Martins, Ana Cristina Simões e Silva, Carolina Neris Cardoso, Karina Braga Gomes, Ana Paula Lucas Mota

Published in: Immunologic Research | Issue 5/2020

Abstract

Cytokine polymorphisms can influence their plasma levels and thus affect the immune response in renal transplantation. A total of 146 renal transplant recipients (RTR) were classified into groups according to the estimated glomerular filtration rate (R1: < 60 and R2: ≥ 60 mL/min/1.73 m²) and time after transplantation (T1: 1 to 24, T2: 25 to 60, T3: 61 to 120, and T4: > 120 months after transplantation). The polymorphisms were genotyped by single specific primer-polymerase chain reaction. IL-10 was measured by ELISA and IL-6, and TNF levels were determined using Miliplex®. A higher frequency of the − 308G allele and the − 308G/G genotype, low-producer, was observed in the R1 group compared with R2. In addition, a higher frequency of the − 308A carriers, high-producer, was found in the R2 group. However, no significant difference was observed in cytokine levels when both groups were compared. Higher levels of IL-6 were observed in T1 compared with T2 and T4 groups. Lower IL-6 levels were found in T2 compared with T3 group. Lower levels of IL-10 were also found in T1 group in relation to T2, while higher levels of this cytokine were observed in T2 group compared with T3. The results suggest that the − 308G > A polymorphism in the TNF gene is associated with filtration function after renal transplantation, and IL-6 and IL-10 levels change according to the time after transplantation. Thus, the joint evaluation of − 308G > A polymorphism in TNF gene and IL-6 and IL-10 levels would provide a broader and effective view on the clinical monitoring of RTR.

Jarl J, Desatnik P, Hansson UP, Prütz KG, Gerdtham U. Do kidney transplantations save money? A study using a before-after design and multiple register-based data from Sweden. Clin Kidney J. 2018;11:283–8.PubMed

Ponticelli C. The mechanisms of acute transplant rejection revisited. J Nephrol. 2012;25:150–8.PubMed

Gu L, Tao Y, Chen C, Ye Y, Xiong X, Sun Y. Initiation of the inflammatory response after renal ischemia/reperfusion injury during renal transplantation. Int Urol Nephrol. 2018;50:2027–35.PubMed

Srinivas L, Vellichirammal NN, Alex AM, Nair C, Nair IV, Banerjee M. Pro-inflammatory cytokines and their epistatic interactions in genetic susceptibility to schizophrenia. J Neuroinflammation. 2016;13:105.PubMedPubMedCentral

Schmid H, Lederer SR. Urinary biomarkers: on the long road to personalized renal transplant medicine. Pol Arch Intern Med. 2019;129:577–9.PubMed

Al-Lamki RS, Mayadas TN. TNF receptors: signaling pathways and contribution to renal dysfunction. Kidney Int. 2015;87:281–96.PubMed

Palladino MA, Bahjat FR, Theodorakis EA, Moldawer LL. Anti-TNF-alpha therapies: the next generation. Nat Rev Drug Discov. 2003;2:736–46.PubMed

Hoffmann U, Bergler T, Rihm M, Pace C, Krüger B, Rümmele P, et al. Upregulation of TNF receptor type 2 in human and experimental renal allograft rejection. Am J Transplant. 2009;9:675–86.PubMed

Sánchez-fructuoso AI, Pérez-Flores I, Valero R, Moreno MA, Fernandez-Arquero M, Urcelay E, et al. The polymorphism −308G/A of tumor necrosis factor-α gene modulates the effect of immunosuppressive treatment in first kidney transplant subjects who suffer an acute rejection. J Immunol Res. 2016;2016:2197595.PubMedPubMedCentral

10.

Akdis M, Burgler S, Crameri R, Eiwegger T, Fujita H, Gomez E, et al. Interleukins, from 1 to 37, and interferon-g: receptors, functions, and roles in diseases. J Allergy Clin Immunol. 2011;127:721–812.

11.

Fielding CA, Jones GW, McLoughlin RM, McLeod L, Hammond VJ, Uceda J, et al. Interleukin-6 signaling drives fibrosis in unresolved inflammation. Immunity. 2014;40:40–50.PubMedPubMedCentral

12.

Wassmann S, Stumpf M, Strehlow K, Schmid A, Schieffer B, Böhm M, et al. Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor. Circ Res. 2004;94:534–41.PubMed

13.

Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, et al. The effect of novel polymorphisms in the interleukin-6 (IL- 6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998;102:369–76.

14.

Jia W, Fei GH, Hu JG, Hu XW. A study on the effect of IL-6 gene polymorphism on the prognosis of non-small-cell lung cancer. Onco Targets Ther. 2015;8:2699–704.PubMedPubMedCentral

15.

Sabat R, Grütz G, Warszawska K, Kirsch S, Witte E, Wolk K, et al. Biology of interleukin-10. Cytokine Growth Factor Rev. 2010;21:331–44.PubMed

16.

Sinuani I, Beberashvili I, Averbukh Z, Sandbank J. Role of IL-10 in the progression of kidney disease. World J Transplant. 2013;3:91–8.PubMedPubMedCentral

17.

Liu F, Li B, Wang WT, Wei YG, Yan LN, Wen TF, et al. Interleukin-10-1082G/A polymorphism and acute liver graft rejection: a meta-analysis. World J Gastroenterol. 2012;18:847–54.PubMedPubMedCentral

18.

Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997;24:1–8.PubMed

19.

Amirzargar A, Lessanpezeshki M, Fathi A, Amirzargar M, Khosravi F, Ansaripour B, et al. Th1/Th2 cytokine analysis in Iranian renal transplant recipients. Transplant Proc. 2005;37:2985–7.PubMed

20.

Elnokeety MM, Shaker AM, Fayed AM. Urinary interleukin-10 in renal transplant recipients: does it predict a state of tolerance or rejection. Saudi J Kidney Dis Transpl. 2017;28:1196–200.PubMed

21.

Karimi MH, Daneshmandi S, Pourfathollah AA, Geramizadeh B, Yaghobi R, Rais-Jalali GA, et al. A study of the impact of cytokine gene polymorphism in acute rejection of renal transplant recipients. Mol Biol Rep. 2012;39:509–15.PubMed

22.

Ashoor IF, Najafian N. Rejection and regulation: a tight balance. Curr Opin Organ Transplant. 2012;17:1–7.PubMedPubMedCentral

23.

Cucchiari D. Podestà Ma, Ponticelli C. the critical role of innate immunity in kidney transplantation. Nephron. 2016;132:227–37.PubMed

24.

Levin A, Stevens PE, Bilous RW, Coresh J, Francisco ALM, Jong PE, et al. Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150.

25.

Miller WG, Jones GRD. Estimated glomerular filtration rate; laboratory implementation and current global status. Adv Chronic Kidney Dis. 2018;25:7–13.PubMed

26.

Rodrigues FB, Bruetto RG, Torres US, Otaviano AP, Zanetta DM, Burdmann EA. Incidence and mortality of acute kidney injury after myocardial infarction: a comparison between KDIGO and RIFLE criteria. PLoS One. 2013;8:e69998.PubMedPubMedCentral

27.

Halloran PF, Langone AJ, Helderman JH, Kaplan B. Assessing long-term nephron loss: is it time to kick the CAN grading system? Am J Transplant. 2004;4:1729–30.PubMed

28.

Samaan F, Requião-Moura LR, Pinheiro HS, Ozaki KS, Câmara NOS, Pacheco-Silva A. Prevalence and progression of chronic kidney disease after renal transplantation. Transplant Proc. 2011;43:2587–91.PubMed

29.

Naderi GH, Mehraban D, Kazemeyni SM, Darvishi M, Latif AH. Living or deceased donor kidney transplantation: a comparison of results and survival rates among Iranian patients. Transplant Proc. 2009;41:2772–4.PubMed

30.

Nemati E, Einollahi B, Lesan Pezeshki M, Porfarziani V, Fattahi MR. Does kidney transplantation with deceased or living donor affect graft survival? Nephrourol Mon. 2014;6:e12182.PubMedPubMedCentral

31.

Terasaki PI, Koyama H, Cecka JM, Gjertson DW. The hyperfiltration hypothesis in human renal transplantation. Transplantation. 1994;57:1450–4.PubMed

32.

Hu Q, Tian H, Wu Q, Li J, Cheng X, Liao P. Interleukin-10-1082 G/a polymorphism and acute renal graft rejection: a meta-analysis. Ren Fail. 2016;38:57–64.PubMed

33.

Perovic V, Markovic M, Kravljaca M, Milosevic E, Djoric M, Pravica V, et al. Cytokine gene polymorphism profiles in kidney transplant patients - association of +1188A/C RS3212227 SNP in the IL12B gene prevents delayed graft function. Arch Med Res. 2018;49:101–8.PubMed

34.

Rashad RH, Mahmoud KM, Hady TMAA, El-Agroudy AEB, Hamdy AF, Ismail AM, et al. IL-10 gene polymorphism and graft outcome in live- donor kidney transplantation. J Egypt Soc Nephrol Transplant. 2016, 2016;16:89–96.

35.

Xiong J, Wang Y, Zhang Y, Nie L, Wang D, Huang Y, et al. Lack of association between interleukin-10 gene polymorphisms and graft rejection risk in kidney transplantation recipients: a meta-analysis. PLoS One. 2015;10:e0127540.PubMedPubMedCentral

36.

Khan F, Sar A, Gonul I, Benediktsson H, Doulla J, Yilmaz S, et al. Graft inflammation and histologic indicators of kidney chronic allograft failure: low-expressing interleukin-10 genotypes cannot be ignored. Transplantation. 2010;90:630–8.PubMed

37.

Thakkinstian A, Dmitrienko S, Gerbase-Delima M, McDaniel DO, Inigo P, Chowet KM, et al. Association between cytokine gene polymorphisms and outcomes in renal transplantation: a meta-analysis of individual patient data. Nephrol Dial Transplant. 2008;23:3017–23.PubMed

38.

La Manna G, Cappuccilli ML, Capelli I, Baraldi O, Cuna V, Battaglino G, et al. The impact of apoptosis and inflammation gene polymorphisms on transplanted kidney function. Ann Transplant. 2013;18:256–64.PubMed

39.

Kocierz M, Siekiera U, Kolonko A, Karkoszka H, Chudek J, Cierpka L, et al. 174G/C interleukin-6 gene polymorphism and the risk of transplanted kidney failure or graft loss during a 5-year follow-up period. Tissue Antigens. 2011;77:283–90.PubMed

40.

Arbab M, Tahir S, Niazi MK, Ishaq M, Hussain A, Siddique PM, et al. TNF-α genetic predisposition and higher expression of inflammatory pathway components in keratoconus. Invest Ophthalmol Vis Sci. 2017;58:3481–7.PubMed

41.

Gendzekhadze K, Rivas-Vetencourt P, Montano RF. Risk of adverse post-transplant events after kidney allograft transplantation as predicted by CTLA-4 +49 and TNF-alpha −308 single nucleotide polymorphisms: a preliminary study. Transpl Immunol. 2006;16:194–9.PubMed

42.

Dhaouadi T, Sfar I, Bardi R, Jendoubi-Ayed S, Abdallah TB, Ayed K, et al. Cytokine gene polymorphisms in kidney transplantation. Transplant Proc. 2013;45:2152–7.PubMed

43.

Masli S, Turpie B. Anti-inflammatory effects of tumour necrosis factor (TNF)-alpha are mediated via TNF-R2 (p75) in tolerogenic transforming growth factor-beta-treated antigen-presenting cells. Immunology. 2009;127:62–72.PubMedPubMedCentral

44.

Balkwill F. Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev. 2002;13:135–41.

45.

Agnoli C, Grioni S, Pala V, Allione A, Matullo G, Gaetano CD, et al. Biomarkers of inflammation and breast cancer risk: a case-control study nested in the EPIC-Varese cohort. Sci Rep. 2017;7:12708.PubMedPubMedCentral

46.

Kleijwegt FS, Laban S, Duinkerken G, Joosten AM, Zaldumbide A, Nikolic T, et al. Critical role for TNF in the induction of human antigen-specific regulatory T cells by tolerogenic dendritic cells. J Immunol. 2010;185:1412–8.PubMed

47.

Salomon BL, Leclerc M, Tosello J, Ronin E, Piaggio E, Cohen JL. Tumor necrosis factor α and regulatory T cells in Oncoimmunology. Front Immunol. 2018;9:444.PubMedPubMedCentral

48.

Pierini A, Strober W, Moffett C, Baker J, Nishikii H, Alvarez M, et al. TNF-α priming enhances CD4+FoxP3+ regulatory T-cell suppressive function in murine GVHD prevention and treatment. Blood. 2016;128:866–71.PubMedPubMedCentral

49.

Bazzaz JT, Amoli MM, Taheri Z, Larijani B, Pravica V, Hutchinson IV. TNF-alpha and IFN-gamma gene variation and genetic susceptibility to type 1 diabetes and its microangiopathic complications. J Diabetes Metab Disord. 2014;13:46.PubMedPubMedCentral

50.

Beyer M, Abdullah Z, Chemnitz JM, Maisel D, Sander J, Lehmann C, et al. Tumor-necrosis factor impairs CD4(+) T cell-mediated immunological control in chronic viral infection. Nat Immunol. 2016;17:593–603.PubMed

51.

Ban L, Zhang J, Wang L, Kuhtreiber W, Burger D, Faustman DL. Selective death of autoreactive T cells in human diabetes by TNF or TNF receptor 2 agonism. Proc Natl Acad Sci U S A. 2008;105:13644–9.PubMedPubMedCentral

52.

Kotowski M, Bogacz A, Bartkowiak-wieczorek J, Sienko J, Procyk D, Dziewanowski K, et al. The influence of the tumor necrosis factor-alpa-308G>A polymorphism on the efficacy of immunosuppressive therapy in patients after kidney transplantation. J Physiol Pharmacol. 2016;67:819–26.

53.

Mota APL, Menezes CA, Alpoim PN, Cardoso CN, Martins SR, Alves LV, et al. Regulatory and pro-inflammatory cytokines in brazilian living-related renal transplant recipients according to creatinine plasma levels. Nephrology (Carlton). 2017;23:867–75.

54.

Alves LV, Maia MJO, Nunes FFC, Magalhães HPB, Afonso DAF, Mota APL. Creatinine and cytokines plasma levels related to HLA compatibility in kidney transplant patients. J Bras Patol Med Lab. 2015;51:303–9.

55.

Newell KA. Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest. 2010;120:1836–47.PubMedPubMedCentral

56.

Nova-Lamperti E, Fanelli G, Becker PD, Chana P, Elgueta R, Dodd PC, et al. IL-10-produced by human transitional B-cells down-regulates CD86 expression on B-cells leading to inhibition of CD4+T-cell responses. Sci Rep. 2016;6:20044.PubMedPubMedCentral

57.

Ma L, Zhang H, Hu K, Lv G, Fu Y, Ayana DA, Zhao P, Jiang Y Desalegn Admassu Ayana. The imbalance between Tregs, Th17 cells and inflammatory cytokines among renal transplant recipients. BMC Immunol 2015;16:56.

58.

Edemir B, Kurian SM, Eisenacher M, Lang D, Müller-Tidow C, Gabriëls G, et al. Activation of counter-regulatory mechanisms in a rat renal acute rejection model. BMC Genomics. 2008;9:71.PubMedPubMedCentral

59.

Mazanowska O, Kamińska D, Krajewska M, Banasik M, Zabińska M, Kościelska-Kasprzak K, et al. Increased plasma tissue inhibitors of metalloproteinase concentrations as negative predictors associated with deterioration of kidney allograft function upon long-term observation. Transplant Proc. 2013;45:1458–61.PubMed

60.

Reinhold SW, Straub RH, Krüger B, Kaess B, Bergler T, Weingart C, et al. Elevated urinary sVCAM-1, IL6, sIL6R and TNFR1 concentrations indicate acute kidney transplant rejection in the first 2 weeks after transplantation. Cytokine. 2012;57(3):379–88.PubMed

61.

Jin Z, Xu C, Duan W, Yang J, Tian P. The level of IL-2 and IL-6 in stimulated peripheral lymphocyte supernatants of kidney transplant recipients can predict acute renal allograft rejection. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2017;33:1024–9.PubMed

62.

Chen X, Oppenheim JJ. Contrasting effects of TNF and anti-TNF on the activation of effector T cells and regulatory T cells in autoimmunity. FEBS Lett. 2011;585:3611–8.PubMedPubMedCentral

63.

Budak D, Yilmaz VT, Akbas H, Suleymanlar G, Yucel G. Association between graft function and serum TNF-α, TNFR1 and TNFR2 levels in patients with kidney transplantation. Ren Fail. 2015;37:871–6.PubMed

64.

Lima JR, Salgado JV, Ferreira TC, Oliveira MI, Santos AM, Salgado Filho N. Cystatin C and inflammatory markers in kidney transplant recipients. Rev Assoc Med Bras (1992). 2011;57:347–52.

65.

Jung YJ, Lee HR, Kwon OJ. Comparison of serum cystatin C and creatinine as a marker for early detection of decreasing glomerular filtration rate in renal transplants. J Korean Surg Soc. 2012;83:69–74.PubMedPubMedCentral

66.

Matsunami M, Ubara Y, Sumida K, Oshima Y, Oguro M, Kinoshita K, et al. The efficacy and safety of anti-interleukin-6 receptor monoclonal blockade in a renal transplant patient with Castleman disease: early post-transplant outcome. BMC Nephrol. 2018;19:263.PubMedPubMedCentral

67.

Simmons EM, Langone A, Sezer MT, Vella JP, Recupero P, Morrow JD, et al. Effect of renal transplantation on biomarkers of inflammation and oxidative stress in end-stage renal disease patients. Transplantation. 2005;79:914–9.PubMed

68.

Kessler B, Rinchai D, Kewcharoenwong C, Nithichanon A, Biggart R, Hawrylowicz CM, et al. Interleukin 10 inhibits pro-inflammatory cytokine responses and killing of Burkholderia pseudomallei. Sci Rep. 2017;7:42791.PubMedPubMedCentral

69.

Boucault L, Bézie S, Ossart J, Guillonneau C. Tolerance in organ transplantation. In: Abdeldayem H, El-Kased AF, El-Shaarawy A, editors. Frontiers in Transplantology. 1rd ed. IntechOpen: Croatia; 2016. p. 47–87.

70.

Cooper JE, Wiseman AC. Novel immunosuppressive agents in kidney transplantation. Clin Nephrol. 2010;73:333–43.PubMed

71.

Sakaguchi S, Wing K, Yamaguchi T. Dynamics of peripheral tolerance and immune regulation mediated by Treg. Eur J Immunol. 2009;39:2331–6.PubMed

72.

Mota AP, Vilaça SS, das Mercês FL Jr, Pinheiro Mde B, Teixeira-Carvalho A, Silveira AC, et al. Cytokines signatures in short and long-term stable renal transplanted patients. Cytokine. 2013;62:302–9.PubMed

Title: TNF, IL-6, and IL-10 cytokines levels and their polymorphisms in renal function and time after transplantation
Authors: Lorraine Vieira Alves
Suellen Rodrigues Martins
Ana Cristina Simões e Silva
Carolina Neris Cardoso
Karina Braga Gomes
Ana Paula Lucas Mota
Publication date: 01-10-2020
Publisher: Springer US
Keywords: Kidney Transplantation
Kidney Transplantation
Kidney Transplantation
Kidney Transplantation
Kidney Transplantation
Cytokines
Kidney Transplantation
Biomarkers
Published in: Immunologic Research / Issue 5/2020
Print ISSN: 0257-277X
Electronic ISSN: 1559-0755
DOI: https://doi.org/10.1007/s12026-020-09147-3

At a glance: The STEP trials

Springer Medicine

TNF, IL-6, and IL-10 cytokines levels and their polymorphisms in renal function and time after transplantation

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2020

Blockade of PD-1 and TIM-3 immune checkpoints fails to restore the function of exhausted CD8+ T cells in early clinical stages of chronic lymphocytic leukemia

Protectin DX ameliorates inflammation in sepsis-induced acute lung injury through mediating PPARγ/NF-κB pathway

Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine

The role of competing mechanisms on Lck regulation

Comparative study between human mesenchymal stem cells and etanercept as immunomodulatory agents in rat model of rheumatoid arthritis

The role of Th17 cells in psoriasis